Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05238558
Title Safety and Immune Response to FMPV-1
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Hubro Therapeutics AS

colorectal cancer


FMPV-1 + Sargramostim

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Quotient Sciences Nottingham NG11 6JS United Kingdom Details
*Shaded cells indicate that there was no data available from for the field